DB05848ExperimentalProtein Based Therapies
The humanized anti-IL-12 antibody is an important addition to PDL's already strong pipeline of humanized antibodies being developed for the treatment of autoimmune diseases. SMART Anti-IL-12 Antibody was humanized at... SMART Anti-IL-12 Antibody was humanized at PDL from a murine anti-IL-12 antibody that was licensed, together with certain intellectual property related to anti-IL-12 therapy, from Hoffmann-La Roche Inc.
- Primary indication
- Investigated for use/treatment in autoimmune diseases and inflammatory disorders (unspecified).Curator reviewed
Resolves to
Targets
What you can answer from here — as of April 02, 2025
1Protein targetEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with humanized SMART Anti-IL-12 Antibody, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account